BackiLex Medical Overview

iLex Medical Profit Margin

Latest profit margin for iLex Medical: 4.39% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

2.25%
↓ 70.86% YoY

As of Jun 2026

Annual Profit Margin (TTM)

4.39%
↓ 11.44% YoY

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

iLex Medical (ILX.TA) FAQ

The latest profit margin for ILX.TA is 4.39% as of June 2026. That compares with 4.96% in the prior-year period — down 11.4% year over year. That is below the sector sector average of 12.13%. Investors often review this figure alongside iLex Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, ILX.TA's profit margin moved from 4.96% to 4.39% — a 11.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in iLex Medical's valuation or profitability profile.

Against its sector companies, ILX.TA currently prints 4.39% for profit margin, while the sector average sits near 12.13%. That is roughly 63.8% below the sector mean. Large gaps often invite a closer look at iLex Medical's growth, margins, and balance sheet.

Profit Margin shows how effectively iLex Medical converts resources into returns. At 4.39%, ILX.TA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 4.96% in the prior-year period — down 11.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ILX.TA's profit margin (4.39%), review year-over-year change from 4.96%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers